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Abstract: Despite concerns about vitamin D deficiency in the Australian population, little is known
about the prevalence and predictors of vitamin D-containing supplement use. We described the use
of vitamin D-containing supplements, and investigated associations between supplemental vitamin
D intake and serum 25-hydroxyvitamin D (25(OH)D) concentrations, using a single 24-h dietary
recall from the 2011–2013 Australian Health Survey (n = 12,153; ages ě 2 years). Multiple regression
models were used to investigate predictors of vitamin D-containing supplement use in adults, and
associations between dose and serum 25(OH)D concentrations/vitamin D sufficiency (ě50 nmol/L),
adjusting for potential confounders. The prevalence of vitamin D-containing supplement use was
10%, 6% and 19% in children, adolescents and adults, respectively. Predictors of vitamin D-containing
supplement use in adults included being female, advancing age, higher educational attainment,
higher socio-economic status, not smoking, and greater physical activity. After adjusting for potential
confounders, a 40 IU (1 µg) increase in vitamin D intake from supplements was associated with an
increase of 0.41 nmol/L in serum 25(OH)D concentrations (95% CI 0.35, 0.47; p < 0.001). However, the
prevalence of vitamin D-containing supplement use was generally low in the Australian population,
particularly for single vitamin D supplements, with most supplement users obtaining only low levels
of vitamin D from other supplement types.
Keywords: vitamin D; supplements; 25-hydroxyvitamin D
1. Introduction
Vitamin D deficiency has traditionally not been considered an important public health issue in
Australia due to the abundance of sunlight. However, Australia has the highest skin cancer incidence
in the world [1] and public health policies have, therefore, emphasised sun protection practices
that limit excessive exposure of the skin to ultraviolet radiation. In a similar timeframe, societal
changes, particularly the advent of the personal computer, has meant that many Australians now lead
predominantly indoor lifestyles. Findings from the 2011 to 2013 Australian Health Survey showed
that 23% of the adult population were vitamin D deficient, defined as serum 25-hydroxyvitamin D
(25(OH)D) concentrations <50 nmol/L [2]. The prevalence of vitamin D deficiency varied by ethnicity,
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and was highest in those born in North Africa, the Middle East and Asia. There is also evidence to
suggest a re-emergence of rickets in some Australian children, particularly in recent migrants with
dark skin [3].
Although the major source of vitamin D in humans is cutaneous synthesis in the presence of
sunlight, when sun exposure is limited (e.g., due to sun protection, working indoors, cultural clothing
habits, season and weather conditions), dietary sources of vitamin D are required to maintain adequate
vitamin D status. Given that natural food sources of vitamin D are limited to meat, fish, eggs, dairy and
mushrooms, with vitamin D present mostly in small amounts, supplementation is an alternative for
increasing vitamin D intakes and status. Vitamin D supplementation has been shown to substantially
increase vitamin D intakes and serum 25(OH)D concentrations in other populations [4–9] and the
prevalence of supplement use is increasing globally [10,11]. However, very little is known about the
prevalence and predictors of vitamin D-containing supplement use in the Australian population.
The 2011–2013 Australian Health Survey collected comprehensive information on dietary
supplement use in a representative sample of the population agedě2 years, along with serum 25(OH)D
concentrations in those agedě12 years measured using internationally-standardised methodology [12].
The aims of this study were to describe the prevalence of vitamin D-containing supplement use in
the Australian population, identify independent predictors of vitamin D-containing supplement
use in adults, and investigate associations between supplemental vitamin D intake and serum
25(OH)D concentrations.
2. Materials and Methods
2.1. Study Population
The 2011–2013 Australian Health Survey was the largest, most comprehensive health survey
ever conducted in Australia, and aimed to provide a better understanding of the health of people
living in Australia [12]. It combined the National Health Survey, the National Nutrition and
Physical Activity Survey (NNPAS) and the National Health Measures Survey. The survey excluded
residents of non-private dwellings and visitors who were not usual residents of the selected dwelling.
Each household contributed either one adult, or one adult plus one child/adolescent.
Core data items were collected for all people in the Australian Health Survey and individuals were
then selected to participate either in the National Health Survey (n = 20,426), which included detailed
health measures and use of medications, or in the NNPAS (n = 12,153). The NNPAS included a dietary
recall of all food, beverages and supplements for participants aged ě2 years. Detailed methodology
of the NNPAS is available elsewhere [12]. In brief, trained interviewers collected information by
face-to-face interview from usual residents of private dwellings in urban and rural areas of Australia.
A second interview was conducted by telephone for a subset of participants. To account for possible
seasonal effects, the NNPAS was conducted over a 12-month period from May 2011 to June 2012.
Those aged ě5 years who participated in the National Health Survey or the NNPAS were invited
to participate in the National Health Measures Survey for measurement of nutrient and chronic disease
biomarkers (urine test for those aged 5–12 years; blood and urine tests for those aged ě12 years).
Qualified phlebotomists collected fasting and non-fasting blood samples from participants aged
ě12 years (n = 10,401) for measurement of biomarkers, including serum 25(OH)D concentrations [12].
No participants were excluded from the National Health Measures Survey due to their health status or
life stage.
The interview components of the NHS and NNPAS were conducted under the Census and
Statistics Act (CSA) 1905. Ethics approval was sought and gained for the NHMS from the Australian
Government Department of Health and Ageing’s Departmental Ethics Committee (Application
Number 2/2011). For the NHMS, informed consent was sought from adults and from parents/legal
guardians of children through completion of a consent form.
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2.2. Use of Vitamin D-Containing Supplements
For the purposes of this study, we used data from the first 24-h dietary recall of the NNPAS.
Participants were asked: “Have you taken any dietary supplements in the last 24 h?” and were encouraged
to have in front of them any supplements taken [12]. The type, brand and AUST L number [13] of
the supplements were recorded, along with the form (e.g., tablet, capsule) and dose. We determined
vitamin D composition data primarily from the Australian Register of Therapeutic Goods, a database
of therapeutic goods which can be lawfully supplied in Australia [13]. In some cases, the supplements
were not listed in the Australian Register of Therapeutic Goods, either because the product has since
been relicensed due to name or formulation change, or the product has been taken off the market.
In these cases, vitamin D composition data were obtained from manufacturers by website, telephone
call, or email communication.
Supplements that contained any vitamin D (either added, or inherent in the case of fish
liver oil) were considered a vitamin D-containing supplement. A participant who reported using
any supplement that contained vitamin D was considered a “vitamin D-containing supplement
user”. Vitamin D-containing supplements were classified as single vitamin D supplements, calcium
preparations (with added vitamin D), multivitamin/mineral (with added vitamin D), fish oil
preparations (with added vitamin D), and fish liver oils (including inherent and added vitamin D).
2.3. Analysis of Serum 25-Hydroxyvitamin D Concentrations
The Australian Health Survey is one of eight participating national surveys in the Vitamin D
Standardization Program (VDSP), which was established by the National Institute of Health Office
of Dietary Supplements in collaboration with the Centers for Disease Control and Prevention and
the National Institute for Standards and Technology (NIST). The VDSP aims to internationally
standardise the analysis of serum 25(OH)D concentrations [14]. Serum 25(OH)D concentrations
for participants aged ě12 years were measured at the Douglass Hanly Moir (DHM) laboratory by a
liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. This laboratory is certified
to the standard reference method developed by NIST and Ghent University [14].
2.4. Participant Characteristics
We categorised age as follows: 2–4, 5–8, 9–11, 12–13, 14–15, 16–17, 18–30, 31–50, 51–70 and
ě71 years. We defined those aged 2–11 years, 12–17 years and ě18 years as children, adolescents and
adults, respectively. For adult participants, we described the following characteristics: sex, age group,
region of birth, State/Territory, education, socioeconomic status, body mass index (BMI) category,
physical activity, smoking, alcohol intake, health condition and self-assessed health.
Region of birth was defined as Australia and New Zealand, Europe, Americas, Asia, Africa and
the Middle East. Season was defined as: Summer (December–February), Autumn (March–May), Winter
(June–August) and Spring (September–November). State/Territory was defined as New South Wales,
Victoria, Queensland, South Australia, Western Australia, Tasmania, Northern Territory and Australian
Capital Territory. Educational attainment was described as none after secondary school, certificate,
Bachelor/Diploma and postgraduate. Socioeconomic status was described by the Socio-Economic
Indexes for Areas (SEIFA) 2011 Index of Relative Socio-Economic Disadvantage (IRSD). This is a
general socio-economic index that summarises a range of information about the economic and social
conditions of people and households within an area, with scores ranging from low (relatively greater
disadvantage in general) to high (relative lack of disadvantage in general) [15]. The SEIFA IRSD was
categorised into quintiles.
BMI was calculated from measured weight (kg) and height (m) (weight/height2), and adults
were categorised as underweight (BMI < 18.5), normal weight (18.5 ď BMI < 25.0), overweight
(25.0 ď BMI < 30.0) or obese (BMI ě 30) [12]. Physical activity was defined as low, moderate, or high
based on the level of physical activity for fitness, recreation, sport, or walking for transport in the past
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week [12]. The data items that contributed to this variable included total minutes undertaking moderate
exercise/physical activity in the last week; total minutes undertaking vigorous exercise/physical
activity in the last week; total minutes walked for fitness, recreation or sport in the last week; and total
minutes spent walking for transport in the last week. Each category of physical activity had an intensity
factor score (e.g., walking for fitness = 3.5, walking for transport = 3.5, moderate exercise/physical
activity = 5 and vigorous exercise/physical activity = 7.5) [12]. The duration of physical activity was
multiplied by the intensity factor score. Different levels of exercise/physical activity were defined as:
low (no exercise to <800); moderate (800 to 1600, or more than 1600 but with less than 1 h vigorous
physical activity); high (>1600 and with 1 h or more of vigorous physical activity).
Smoking was defined as “current smoker”, “ex-smoker” and “never smoked”. Alcohol intake
(g/day) was measured by the 24-h dietary recall. Health condition was defined as “yes” or “no”
based on whether the participant had ever been told by a medical practitioner that they had one or
more of the following conditions (either current or past): diabetes, kidney disease, high cholesterol,
high sugar levels, hypertensive disease, ischaemic heart disease, heart failure or other heart disease,
cerebrovascular disease, oedema or angina. Self-assessed health was measured as excellent, very good,
good, fair or poor.
2.5. Statistical Analysis
The prevalence of vitamin D-containing supplement use in the total population was reported by
sex, age group and type of supplement used. We determined the proportion of children, adolescents
and adults exceeding the Tolerable Upper Intake Level (UL) of vitamin D from supplements on the
recording day. The UL is the maximum level of chronic daily intake of a nutrient that is unlikely to
pose a risk of adverse health effects to humans [16]. The UL was defined as 2500 IU (62.5 µg) for
children aged 1–3 years; 3000 IU (75 µg) for children aged 4–8 years; and 4000 IU (100 µg) for those
aged ě9 years, as per the 2011 Institute of Medicine guidelines [17].
We described characteristics of adult vitamin D-containing supplement users and non-users
(n = 9435), using number and proportion for categorical variables, and median (interquartile range, IQR)
for alcohol intake (g/day). Characteristics of users and non-users of vitamin D-containing supplements
were compared using Pearson’s chi-square tests for categorical variables, and the Mann-Whitney U
test for alcohol intake.
We used univariate logistic regression to investigate the relationship between vitamin
D-containing supplement use in children/adolescents and adults in the same household (n = 2634
households; n = 5268 individuals). We used multiple logistic regression to investigate the potential
predictors of vitamin D-containing supplement use in adults, namely sex, age group, region of birth,
State/Territory, season, education, SEIFA, BMI category, physical activity, smoking, alcohol intake,
health condition and self-assessed health (n = 7751).
We reported the median and IQR for serum 25(OH)D concentrations in adults (stratified by sex
and age group) for those taking no vitamin D-containing supplements, and for those taking <400 IU
(<10 µg), 400–999 IU (10–24.9 µg), and ě1000 IU (ě25 µg) of supplemental vitamin D (n = 9435).
The 400 IU (10 µg) cut-off was chosen to reflect the Estimated Average Requirement of vitamin D for
for all ages above one year, assuming minimal sunlight exposure [17], while the 1000 IU (25 µg) cut-off
was chosen to reflect the usual daily dose in single vitamin D supplements.
Using Pearson’s chi-square tests, we compared the major characteristics (sex, age group, region
of birth, education and SEIFA) of participants with measured serum 25(OH)D concentrations (i.e.,
those who agreed to have their blood taken for the measurement of biomarkers, n = 3736) versus those
without measured serum 25(OH)D concentrations (i.e., those who did not agree to have their blood
taken for the measurement of biomarkers, n = 5699).
We examined associations between vitamin D intake from supplements (as a continuous variable)
and serum 25(OH)D concentrations in adults using multiple linear regression models. Models were
run unadjusted (n = 3736) and adjusted for sex, age group, region of birth, State/Territory, education,
SEIFA, BMI category, physical activity, smoking, alcohol intake, health condition and self-assessed
health (n = 3471). Further, we examined the association between vitamin D intake from supplements
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and vitamin D sufficiency (defined asě50 nmol/L as per the 2011 Institute of Medicine guidelines [17])
in adults using multiple logistic regression, adjusting for the variables above (n = 3471). In order to
assess whether the associations varied by sex or by season of blood collection, we also stratified these
analyses by sex and season.
Analyses were performed using IBM SPSS Statistics Release Version 19.9.9.1 (IBM SPSS Inc., 2010,
Chicago, IL, USA) and statistical significance was defined as two-tailed p < 0.05.
3. Results
3.1. Prevalence of Vitamin D-Containing Supplement Use
Overall, 17% (n = 2039) of participants reported using a vitamin D-containing supplement on the
recording day: 10% (n = 176) of children, 6% (n = 63) of adolescents and 19% (n = 1800) of adults (Table 1).
In adults, there was a clear sex difference in the prevalence of vitamin D-containing supplement
use (Figure 1), with 24% of females and 13% of males using vitamin D-containing supplements.
The characteristics of adult vitamin D supplement users and non-users are shown in Table 2. 
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Figure 1. Prevalence of vitamin D-containing supplement use by sex and age group in the Australian
population (n = 12,153).
Table 1. Prevalence of vitamin D-containing supplement use in the Australian population (n = 12,153)
by sex, age group and supplement type.
2–11 Years 12–17 Years 18–30 Years 31–50 Years 51–70 Years ě71 Years ě2 Years ě18 Years
n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Total
All types 176 (10.3) 63 (6.3) 224 (13.3) 629 (17.6) 624 (21.5) 323 (25.3) 2039 (16.8) 1800 (19.1)
Single vitamin D 1 (0.1) 5 (0.5) 26 (1.5) 104 (2.9) 218 (7.5) 147 (11.5) 501 (4.1) 495 (5.2)
Calcium 1 17 (1.0) 6 (0.6) 5 (0.3) 67 (1.9) 157 (5.4) 72 (5.6) 324 (2.7) 301 (3.2)
MVMM 1 155 (9.1) 50 (5.0) 179 (10.6) 460 (12.9) 300 (10.3) 128 (10.0) 1272 (10.5) 1067 (11.3)
Fish oil 1 7 (0.4) 7 (0.7) 26 (1.5) 50 (1.4) 42 (1.4) 15 (1.2) 147 (1.2) 133 (1.4)
Fish liver oil 2 4 (0.2) 0 (0.0) 1 (0.1) 10 (0.3) 16 (0.6) 16 (1.3) 47 (0.4) 43 (0.5)
Males
All types 87 (10.2) 33 (6.4) 86 (10.9) 216 (12.9) 179 (13.3) 94 (17.6) 695 (12.2) 575 (13.3)
Single vitamin D 1 (0.1) 1 (0.2) 6 (0.8) 27 (1.6) 51 (3.8) 36 (6.8) 122 (2.1) 120 (2.8)
Calcium 1 9 (1.1) 3 (0.6) 3 (0.4) 14 (0.8) 19 (1.4) 11 (2.1) 59 (1.0) 47 (1.1)
MVMM 1 75 (8.8) 26 (5.0) 68 (8.7) 161 (9.6) 99 (7.4) 45 (8.4) 474 (8.3) 373 (8.6)
Fish oil 1 3 (0.4) 4 (0.8) 14 (1.8) 28 (1.7) 19 (1.4) 6 (1.1) 74 (1.3) 67 (1.5)
Fish liver oil 2 2 (0.2) 0 (0.0) 0 (0.0) 5 (0.3) 4 (0.3) 6 (1.1) 17 (0.3) 15 (0.3)
Females
All types 89 (10.4) 30 (6.1) 138 (15.3) 413 (21.8) 445 (28.4) 229 (30.7) 1344 (20.8) 1225 (24.0)
Single vitamin D 0 (0.0) 4 (0.8) 20 (2.2) 77 (4.1) 167 (10.7) 111 (14.9) 379 (5.9) 375 (7.3)
Calcium 1 8 (0.9) 3 (0.6) 2 (0.2) 53 (2.8) 138 (8.8) 61 (8.2) 265 (4.1) 254 (5.0)
MVMM 1 80 (9.3) 24 (4.9) 111 (12.3) 299 (15.8) 201 (12.8) 83 (11.1) 798 (12.4) 694 (13.6)
Fish oil 1 4 (0.5) 3 (0.6) 12 (1.3) 22 (1.2) 23 (1.5) 9 (1.2) 73 (1.1) 66 (1.3)
Fish liver oil 2 2 (0.2) 0 (0.0) 1 (0.1) 5 (0.3) 12 (0.8) 10 (1.3) 30 (0.5) 28 (0.5)
1 With added vitamin D; 2 Inherent vitamin D with/without added vitamin D; MVMM, multivitamin-multimineral.
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Table 2. Characteristics of vitamin D-containing supplement users and non-users among Australian
adults (n = 9435).
n % Across Rows n % Across Rows p
Vitamin D-Containing
Supplement User
Vitamin D-Containing
Supplement Non-User
Sex 1800 7635 <0.001
Male 575 13 3754 87
Female 1225 24 3881 76
Age Group 1800 7635 <0.001
18–30 years 224 13 1462 87
31–50 years 629 18 2936 82
51–70 years 624 21 2282 79
ě71 years 323 25 955 75
Region of birth 1800 7635 0.009
Australia and New Zealand 1277 18 5729 82
Europe 275 21 1017 79
Americas 26 21 98 79
Asia 166 22 574 78
Africa and Middle East 56 21 217 79
State/Territory 1800 7635 <0.001
New South Wales 312 19 1345 81
Victoria 276 20 1085 80
Queensland 271 18 1239 82
South Australia 248 21 952 79
Western Australia 258 19 1067 81
Tasmania 205 21 791 79
Northern Territory 68 12 507 88
Australian Capital Territory 162 20 649 80
Education 1767 7524 <0.001
None after school 601 16 3103 84
Certificate 366 17 1849 83
Bachelor/Diploma 597 23 2005 77
Postgraduate 203 26 567 74
SEIFA 1800 7635 <0.001
Lowest 20% 270 15 1508 85
Second quintile 360 18 1601 82
Third quintile 397 21 1476 79
Fourth quintile 379 20 1537 80
Highest 20% 394 21 1513 79
BMI category 1527 6431 0.491
Underweight 24 20 97 80
Normal weight 544 20 2192 80
Overweight 559 19 2339 81
Obese 400 18 1803 82
Physical activity 1777 7551 0.218
Low 1001 18 4425 82
Moderate 512 20 2062 80
High 264 20 1064 80
Smoking 1800 7635 <0.001
Current smoker 197 11 1588 89
Ex-smoker 660 21 2417 79
Never smoked 943 21 3630 79
Alcohol (g/day) (median, IQR) 1800 0.0 (14.4) 7635 0.0 (16.3) 0.006
Health condition 1800 7635 <0.001
Yes 912 22 3155 78
No 888 17 4480 83
Self-assessed health 1800 7635 0.738
Excellent 286 19 1251 81
Very good 647 19 2676 81
Good 556 19 2409 81
Fair 217 19 946 81
Poor 94 21 353 79
IQR, interquartile range.
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All single vitamin D supplements used by participants provided a daily vitamin D dose of 1000 IU
(25 µg) (Table 3). The median daily dose of vitamin D was 200 IU (5 µg) for multivitamin/mineral,
calcium and fish oil preparations; and 80 IU (2 µg) for fish liver oil. The most commonly used vitamin
D-containing supplement type was the multivitamin/mineral (males 8%; females 12%) (Table 1).
Only 2% of males and 6% of females reported using a single vitamin D supplement, but the prevalence
increased with age (7% of males and 15% of females aged ě71 years). In households with one adult
and one child/adolescent participant (n = 2634 households), children/adolescents were three times
more likely to take a vitamin D-containing supplement if the adult was also a vitamin D-containing
supplement user (OR 3.2; 95% CI 2.4, 4.3; p < 0.001).
Table 3. Description of vitamin D dose (IU (µg)/day) in vitamin D-containing supplements used by
survey participants.
Type of Supplement Minimum Maximum Median IQR
Single vitamin D 1000 (25.0) 1000 (25.0) 1000 (25.0) 0 (0.0)
Multivitamin/mineral 4 (0.1) 1000 (25.0) 200 (5.0) 224 (5.6)
Calcium preparation 5.2 (1.3) 1000 (25.0) 200 (5.0) 200 (5.0)
Fish oil preparation 4 (0.1) 1000 (25.0) 200 (5.0) 264 (6.6)
Fish liver oil 8 (0.2) 252 (6.3) 80 (2.0) 40 (1.0)
IQR, interquartile range.
Among the users of vitamin D-containing supplements, 93% of children/adolescents took one
vitamin D supplement, while 7% took two vitamin D-containing supplements on the recording day.
Among adult users of vitamin D-containing supplements, 86% reported taking one, 13% reported
taking two, and 1% reported taking three or more vitamin D-containing supplements on the recording
day. Among the users of vitamin D-containing supplements, 47%, 24% and 29% took a daily dose of
(<400 IU (<10 µg), 400–999 IU (10–24.9 µg) and (ě1000 IU (ě25 µg), respectively. On the recording day,
no children/adolescents exceeded the UL for their age group, and 0.1% of adults (9/9435) exceeded
the UL of 4000 IU (100 µg).
3.2. Independent Predictors of Vitamin D-Containing Supplement Use
Multiple logistic regression analysis in adults showed that females were more than twice as likely
as males to use a vitamin D-containing supplement, and the prevalence of use increased significantly
with age group (Table 4). Other predictors of vitamin D-containing supplement use included higher
educational attainment, higher socio-economic status, greater physical activity and residential location
(highest use in those in Tasmania). Those with at least one health condition and poorer self-assessed
health were more likely to use a vitamin D-containing supplement. The prevalence of use was higher
in all quintiles of SEIFA compared with the lowest quintile, and in ex-smokers and non-smokers
compared with current smokers. There were no significant associations between season or BMI
category and vitamin D-containing supplement use.
Table 4. Adjusted logistic regression model investigating independent predictors of vitamin
D-containing supplement use in Australian adults (n = 7751).
Adjusted OR (95% CI) p
Sex (female vs. male) 2.05 (1.80, 2.33) <0.001
Age group <0.001
18–30 years Reference category
31–50 years 1.36 (1.12, 1.64) 0.002
51–70 years 2.00 (1.60, 2.41) <0.001
71 years and over 2.40 (1.88, 3.05) <0.001
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Table 4. Cont.
Adjusted OR (95% CI) p
Sex (female vs. male) 2.05 (1.80, 2.33) <0.001
Region of birth 0.088
Australia and New Zealand Reference category
Europe 0.97 (0.82, 1.15) 0.705
Americas 1.21 (0.75, 1.94) 0.435
Asia 1.26 (1.01, 1.57) 0.044
Africa and Middle East 1.38 (1.00, 1.92) 0.052
State/Territory 0.002
New South Wales Reference category
Victoria 1.19 (0.97, 1.46) 0.104
Queensland 0.99 (0.81, 1.22) 0.949
South Australia 1.22 (0.98, 1.50) 0.074
Western Australia 1.11 (0.90, 1.36) 0.344
Tasmania 1.30 (1.04, 1.63) 0.023
Northern Territory 0.64 (0.46, 0.88) 0.007
Australian Capital Territory 1.10 (0.86, 1.40) 0.460
Season 0.415
Summer Reference category
Autumn 1.12 (0.96, 1.31) 0.151
Winter 1.10 (0.93, 1.30) 0.267
Spring 1.14 (0.96, 1.34) 0.150
Education <0.001
None after school Reference category
Certificate 1.27 (1.08, 1.50) 0.004
Bachelor/Diploma 1.63 (1.40, 1.89) <0.001
Postgraduate 1.87 (1.44, 2.42) <0.001
SEIFA <0.001
Lowest 20% Reference category
Second quintile 1.27 (1.04, 1.55) 0.017
Third quintile 1.65 (1.35, 2.01) <0.001
Fourth quintile 1.31 (1.07, 1.61) 0.009
Highest 20% 1.31 (1.06, 1.61) 0.012
BMI category 0.160
Normal weight Reference category
Overweight 0.99 (0.86, 1.14) 0.876
Obese 0.85 (0.73, 1.00) 0.050
Underweight 1.12 (0.70, 1.81) 0.638
Physical activity 0.006
Low Reference category
Moderate 1.09 (0.95, 1.25) 0.205
High 1.34 (1.12, 1.61) 0.002
Smoking <0.001
Current smoker Reference category
Ex-smoker 1.73 (1.42, 2.10) <0.001
Never smoked 1.58 (1.30, 1.91) <0.001
Alcohol (g/day) 1.00 (1.00, 1.00) 0.802
Health condition (yes v no) 1.24 (1.09 1.42) 0.001
Self-assessed health 0.019
Excellent Reference category
Very good 1.22 (1.02, 1.46) 0.032
Good 1.31 (1.08, 1.59) 0.005
Fair 1.30 (1.03, 1.66) 0.031
Poor 1.64 (1.19, 2.26) 0.003
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3.3. Associations with Serum 25-Hydroxyvitamin D Concentrations
Participants with measured serum 25(OH)D concentrations were significantly younger (p < 0.001)
and had a higher level of education (p < 0.001) than those without measured 25(OH)D concentrations.
There were no significant differences in sex, region of birth and SEIFA in those with and without
measured 25(OH)D concentrations.
There was a trend towards higher serum 25(OH)D concentrations with increasing dose of
supplemental vitamin D intake in adults, which was particularly evident in those aged ě51 years
(Figure 2). In an unadjusted model, vitamin D intake (per 40 IU (1 µg)) from supplements was
associated with higher serum 25(OH)D concentrations (coefficient = 0.37; 95% CI 0.31, 0.43; p < 0.001).
The association remained after adjusting for sex, age group, State/Territory, region of birth, season of
interview, education, SEIFA, BMI category, physical activity, smoking, alcohol intake, health condition,
and self-assessed health: a 40 IU (1 µg) increase in vitamin D intake from supplements was associated
with an increase of 0.41 nmol/L in serum 25(OH)D concentrations (95% CI 0.35, 0.47; p < 0.001).
When stratified by sex, there was a slightly stronger effect in males (Coefficient = 0.49; 95% CI 0.37,
0.61; p < 0.001) than in females (Coefficient = 0.38; 95% CI 0.32, 0.45; p < 0.001). When stratified
by season, the association between vitamin D intake and serum 25(OH)D concentrations differed
marginally depending on season: winter (Coefficient = 0.39; 95% CI 0.27, 0.51; p < 0.001); spring
(Coefficient = 0.37; 95% CI 0.25, 0.49; p < 0.001); summer (Coefficient = 0.37; 95% CI 0.25, 0.49; p < 0.001);
autumn (Coefficient = 0.48; 95% CI 0.37, 0.59; p < 0.001).
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Figure 2. Mean serum 25-hydroxyvitamin D (25(OH)D) concentrations by vitamin D supplement dose
and age group among Australian adults (n = 3736).
Vitamin D intake (per 40 IU (1 µg)) was positively associated with vitamin D sufficiency, defined
as ě50 nmol/L (OR 1.08 per 40 IU (1 µg) increase in supplemental vitamin D; 95% CI 1.06, 1.10;
p < 0.001) after adjusting for the potential confounders above. When stratified by sex, there was little
difference in the association between vitamin D intake and vitamin D status in males (OR 1.07; 95%
CI 1.04, 1.11; p < 0.001) and females (OR 1.09; 95% CI 1.07, 1.12; p < 0.001). When stratified by season,
the association between vitamin D intake and vitamin D sufficiency was marginally more pronounced
in winter (OR 1.13; 95% CI 1.08, 1.19; p < 0.001) than spring (OR 1.08; 95% CI 1.04, 1.12; p < 0.001),
summer (OR 1.06; 95% CI 1.02, 1.11; p = 0.003) and autumn (OR 1.09; 95% CI 1.05, 1.13; p < 0.001).
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4. Discussion
This study provides new information on the prevalence and predictors of vitamin D-containing
supplement use in the Australian population, based on nationally representative data. We found
that 10% of children, 6% of adolescents and 19% of adults reported using a vitamin D-containing
supplement. In accordance with other studies [6,9,18], the prevalence of vitamin D-containing
supplement use in adults was higher in females than males, with the highest prevalence of use
being in older females. The prevalence of vitamin D-containing supplement use reported in the United
States (US) and Canada is substantially higher than that reported in our study. For example, in the
2005–2006 National Health and Nutrition Examination Survey (NHANES), vitamin D supplement
use in the US ranged from 16% to 43% in children/adolescents, and from 21% to 49% in adults,
depending on sex and age group [13]. In the 2007–2009 Canadian Health Measures Survey (CHMS),
31% of 6–79 year olds reported using vitamin D-containing supplements, with the majority of users
being female [9]. Both the NHANES and CHMS employed questionnaires that captured vitamin
D-containing supplement use in the previous month, as opposed to the single 24-h dietary recall
used in our study. Nevertheless, there may genuinely be a higher prevalence of vitamin D-containing
supplement use in the US and Canada compared with Australia, since the importance of dietary
vitamin D is emphasised in these countries, with vitamin D food fortification also widely practiced.
In addition, Canada and parts of the US lie at high latitudes where cutaneous synthesis of vitamin
D is limited during winter months, necessitating diet and supplements as an alternative source of
vitamin D.
In Ireland, vitamin D-containing supplements were used by 16% of the adult population based
on data derived from a 4-day food record from the 2009 National Adult Nutrition Survey [8]. This is
similar to the prevalence observed in our study of Australians. However, in a 7-day food record from
the 2004 Irish Children’s and 2006 Irish Teens’ Food Consumption Surveys, vitamin D-containing
supplement use was 21% in 5–8 year olds, 16% in 9–12 year olds and 15% in 13–17 year olds [4], which
is substantially higher than in our study. This higher prevalence of supplement use amongst children
and adolescents may again reflect an awareness of the importance of vitamin D supplementation in a
country of high latitude and inclement weather conditions.
Overall, relatively few participants in our study used a single vitamin D supplement—the most
commonly used vitamin D-containing supplement type was the multivitamin/mineral. Users of
multivitamin/minerals, fish oil and fish liver oil are likely to be taking these supplements for nutritional
qualities other than vitamin D. Low dose vitamin D-containing supplements, such as those found
in most multivitamin/mineral preparations, are not sufficient to alleviate vitamin D deficiency and
may not provide health benefits such as prevention of falls in the elderly. In our study, the highest
prevalence of vitamin D-containing supplement use and single vitamin D supplement use was in
females aged ě51 years, who are the group with the greatest risk of osteoporosis with increasing age.
The greater use of single vitamin D supplements in this population group may reflect a response to
recommendations from health professionals to ensure adequate vitamin D status, particularly for
reducing risk of falls and fractures. Although nine adults exceeded the UL as defined by the Institute
of Medicine as 4000 IU (100 µg), some studies have shown no adverse effects with higher daily doses
e.g., 6400 IU (160 µg) [19] and 10,000 IU (250 µg) [17].
Higher level of education and higher SEIFA were associated with vitamin D-containing
supplement use in the Australian population. Such a pattern is consistent with that reported
in other studies [9,18]. This pattern is also apparent in overall dietary supplement use in some
countries, including Canada [20] and the US [21,22]. Focus groups in Canada have shown that cost,
accessibility, knowledge about what to purchase and lack of information are the most common barriers
to supplement use [23]. In Australia, vitamin D supplements are available over-the-counter, and there
are no subsidies available for low-income earners who are recommended vitamin D supplements by
their general practitioner.
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As with other studies, we found a trend towards higher prevalence of vitamin D-containing
supplement use in those who were most physically active. Higher overall dietary supplement use
in those who are physically active has been reported in other studies [22,24] and may be due to the
perceived benefits of dietary supplements on performance [25] or more health-conscious behaviours
in general [26]. Although we found no association between BMI category and vitamin D-containing
supplement use, there is evidence of lower serum 25(OH)D concentrations with increased adiposity [27–29].
We found that adults born in Asia were more likely to use vitamin D-containing supplements
compared with those born in Australia and New Zealand. Despite the fact that vitamin D deficiency is
higher during winter months in most regions of Australia [2], we found no seasonal differences in the
prevalence of vitamin D-containing supplement use. The use of vitamin D-containing supplements
was least likely among adults living in the Northern Territory and most likely among adults living in
Tasmania. This is in line with the relatively low risk of vitamin D deficiency in those residing closer
compared to further from the equator (e.g., Northern Territory compared to Tasmania) [2].
As expected, vitamin D intake from supplements was independently associated with higher
serum 25(OH)D concentrations and with greater likelihood of vitamin D sufficiency (ě50 nmol/L),
a finding supported by population-based studies in Canada [7,9]. Our results show that a 1000 IU
(25 µg) dose of supplemental vitamin D (the standard daily dose in a single vitamin D supplement)
equates to an average increase in serum 25(OH)D concentrations of 10 nmol/L, and that those who
use a single vitamin D-containing supplement are significantly more likely to be vitamin D sufficient
than those who do not take a supplement. It should be noted, however, that although the Institute
of Medicine suggest that practically all persons are sufficient at serum 25(OH)D concentrations of
ě50 nmol/L, the value of >75 nmol/L has been proposed by others [30]. Furthermore, there is some
evidence to suggest that concentrations of 75–100 nmol/L are required for optimal health, particularly
in relation to non-skeletal health outcomes [31].
A strength of our study was the availability of comprehensive dietary and demographic data
from a nationally representative survey. Supplement intake data were collected directly from
participants using face-to-face interview and participants were encouraged to have in front of them any
supplements taken. Vitamin D composition data for each product were transcribed from the Australian
Register of Therapeutic Goods or from manufacturers’ information, ensuring that composition data
were accurate at brand and product level. It should be noted, however, that this study was based
on supplement intake data from a single 24-h dietary recall, and use on any particular day may not
reflect consistent and long-term use of supplements. In addition, we found that adult participants who
provided a blood sample for measurement of serum 25(OH)D concentrations were younger and had a
higher level of education than adult participants who did not provide a blood sample. For this reason,
associations between supplement dose and serum 25(OH)D concentrations/vitamin D status may not
be generalisable to the total population.
5. Conclusions
To our knowledge, this is the first detailed investigation of vitamin D-containing supplement
use in a nationally-representative sample of the Australian population. Consistent with international
populations, the predictors of vitamin D-containing supplement use include higher socio-economic
status, higher educational attainment and higher levels of physical activity. We found that the use
of vitamin D-containing supplements was independently associated with higher serum 25(OH)D
concentrations and the likelihood of vitamin D sufficiency. However, the prevalence of vitamin
D-containing supplement use was generally low in the Australian population, particularly for single
vitamin D supplements, with most supplement users obtaining only low levels of vitamin D from
other supplement types. Promoting safe levels of sun exposure for optimal health, and introducing
food-based strategies to increase vitamin D in the food supply, are likely to include a larger section
of the population and may be more effective in reducing the prevalence of vitamin D deficiency
in Australia.
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